Matches in SemOpenAlex for { <https://semopenalex.org/work/W4364320852> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4364320852 endingPage "20" @default.
- W4364320852 startingPage "20" @default.
- W4364320852 abstract "Introduction: In Indonesia, the most commom uropatogen E. coli resistance has been to ampicillin (91.9%), ciprof loxacin (83.7%) and cefixime (67.6%). α-mangostin, a chemical compound, has been developed as a new antibiotics isolaated from herbal Garcinia mangostana L, but its effectiveness against multiresistant uropathogenic E. Coli has not been established.Objective: This study examined the effect of α-mangostin on growth of multiresistant E. coliMethods: α-mangostin Treatment of E. coli uropatogen bacteria was administered in vitro, using 14 levels of concentration 14; 28,13; 56.25; 112.5;225; And 450 μg/mL with 4 times replication at each concentration. The antibacterial activity of α-mangostin was determined by evaluating bacterial growth at each concentration using the indirect method by sample absorbance reading. The Samples of uropatogen of E. coli treated with various doses of α-mangostin were incubated for 18-20 hours and then subjected to the absorbance reading using a UV-Vis spectrophotometer λ 625 nm.Results: Minimum inhibitory concentration (MIC) in this study was 450 mg/mL. Based on linear regression (STATA 13.1) relationship betweenα-mangostin concentrations and bacterial growth inhibition activity showed 0.0001 <0.05 showing that all concentrations of α-mangostin simultaneously had a significant effect on the growth of uropathogenic E. coli.Conclusion: α-mangostin has not been effective to inhibit the growth of multiresistent uropathogentic E. coli due to a relatively high MIC (450 mcg/mL).a Potentially relevant activity in the clinical setting will occur if the value of the MIC of a substance in vitro <100 μg /mL. Even the pharmaceutical industry prefers the development of antibiotics with in vitro MIC value of ≤ 2 μg/mL." @default.
- W4364320852 created "2023-04-12" @default.
- W4364320852 creator A5030611650 @default.
- W4364320852 creator A5065166135 @default.
- W4364320852 creator A5066901399 @default.
- W4364320852 date "2017-04-04" @default.
- W4364320852 modified "2023-09-27" @default.
- W4364320852 title "In Vitro Effect of Alfa Mangostin on Multiresistant Uropathogenic Escherichia Coli" @default.
- W4364320852 doi "https://doi.org/10.30659/sainsmed.v8i1.1002" @default.
- W4364320852 hasPublicationYear "2017" @default.
- W4364320852 type Work @default.
- W4364320852 citedByCount "0" @default.
- W4364320852 crossrefType "journal-article" @default.
- W4364320852 hasAuthorship W4364320852A5030611650 @default.
- W4364320852 hasAuthorship W4364320852A5065166135 @default.
- W4364320852 hasAuthorship W4364320852A5066901399 @default.
- W4364320852 hasBestOaLocation W43643208521 @default.
- W4364320852 hasConcept C104317684 @default.
- W4364320852 hasConcept C176947019 @default.
- W4364320852 hasConcept C17741926 @default.
- W4364320852 hasConcept C185592680 @default.
- W4364320852 hasConcept C202751555 @default.
- W4364320852 hasConcept C2778243283 @default.
- W4364320852 hasConcept C2909826119 @default.
- W4364320852 hasConcept C31903555 @default.
- W4364320852 hasConcept C43617362 @default.
- W4364320852 hasConcept C501593827 @default.
- W4364320852 hasConcept C523546767 @default.
- W4364320852 hasConcept C54355233 @default.
- W4364320852 hasConcept C547475151 @default.
- W4364320852 hasConcept C55493867 @default.
- W4364320852 hasConcept C556039675 @default.
- W4364320852 hasConcept C64778159 @default.
- W4364320852 hasConcept C71924100 @default.
- W4364320852 hasConcept C86803240 @default.
- W4364320852 hasConcept C89423630 @default.
- W4364320852 hasConcept C98015330 @default.
- W4364320852 hasConceptScore W4364320852C104317684 @default.
- W4364320852 hasConceptScore W4364320852C176947019 @default.
- W4364320852 hasConceptScore W4364320852C17741926 @default.
- W4364320852 hasConceptScore W4364320852C185592680 @default.
- W4364320852 hasConceptScore W4364320852C202751555 @default.
- W4364320852 hasConceptScore W4364320852C2778243283 @default.
- W4364320852 hasConceptScore W4364320852C2909826119 @default.
- W4364320852 hasConceptScore W4364320852C31903555 @default.
- W4364320852 hasConceptScore W4364320852C43617362 @default.
- W4364320852 hasConceptScore W4364320852C501593827 @default.
- W4364320852 hasConceptScore W4364320852C523546767 @default.
- W4364320852 hasConceptScore W4364320852C54355233 @default.
- W4364320852 hasConceptScore W4364320852C547475151 @default.
- W4364320852 hasConceptScore W4364320852C55493867 @default.
- W4364320852 hasConceptScore W4364320852C556039675 @default.
- W4364320852 hasConceptScore W4364320852C64778159 @default.
- W4364320852 hasConceptScore W4364320852C71924100 @default.
- W4364320852 hasConceptScore W4364320852C86803240 @default.
- W4364320852 hasConceptScore W4364320852C89423630 @default.
- W4364320852 hasConceptScore W4364320852C98015330 @default.
- W4364320852 hasIssue "1" @default.
- W4364320852 hasLocation W43643208521 @default.
- W4364320852 hasOpenAccess W4364320852 @default.
- W4364320852 hasPrimaryLocation W43643208521 @default.
- W4364320852 hasRelatedWork W10007496 @default.
- W4364320852 hasRelatedWork W1968602861 @default.
- W4364320852 hasRelatedWork W1986160804 @default.
- W4364320852 hasRelatedWork W2061297944 @default.
- W4364320852 hasRelatedWork W2090280039 @default.
- W4364320852 hasRelatedWork W2406586849 @default.
- W4364320852 hasRelatedWork W2761665990 @default.
- W4364320852 hasRelatedWork W3178472217 @default.
- W4364320852 hasRelatedWork W3184993864 @default.
- W4364320852 hasRelatedWork W3429368 @default.
- W4364320852 hasVolume "8" @default.
- W4364320852 isParatext "false" @default.
- W4364320852 isRetracted "false" @default.
- W4364320852 workType "article" @default.